ArticleFrontiers in pain research (Lausanne, Switzerland)2025
Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study.
Article in Frontiers in pain research (Lausanne, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- In the Mouth or in the Gut? Innovation Through Implementing Oral and Gastrointestinal Health Science in Chronic Pain Management.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Excessive polypharmacy, which can be defined as the concurrent use of ≥10 medications, is prevalent among individuals with chronic pain. However, it remains unclear how it may vary between individuals or over time. Objectives: This study aimed to describe and identify factors associated with trajectories of excessive polypharmacy. Methods: A retrospective longitudinal study was conducted using the TorSaDE Cohort, which links Canadian Community Health Surveys (2007-2016) and Quebec health administrative databases. Among 9,156 adults living with chronic pain and covered by public prescribed drug insurance, the presence of excessive polypharmacy (yes/no) was assessed monthly for one-year post-survey completion (12 time points). Group-based trajectory modelling was applied to identify groups with similar patterns over time (trajectories). Multivariable multinomial regression was used to identify factors associated with trajectory membership. Results: Four trajectories were obtained: (1) "No excessive polypharmacy" (74.8%); (2) "Sometimes in excessive polypharmacy" (8.6%); (3) "Often in excessive polypharmacy" (6.1%); 4) "Always in excessive polypharmacy" (10.5%). Factors associated with the "always in excessive polypharmacy" trajectory membership were: being older, being born in Canada, having a lower income, having a higher comorbidity index score, more severe pain intensity, and more daily activities prevented by pain, reporting arthritis or back pain and poorer perceived general health, and having a family physician. Using opioids or benzodiazepines, having a lower alcohol consumption, doing less physical activity, a higher number of prescribers and visits to a family physician also predicted being always in excessive polypharmacy. Discussion: This study identifies distinct trajectories of excessive polypharmacy in adults with chronic pain, emphasizing key sociodemographic and clinical factors and the need for tailored interventions for effective medication management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.